Navigator Medicines files Form D for $40 million offering
The Delaware biotechnology company registered a new exempt securities notice with the SEC, reporting $10 million already raised from three investors.
SEC filing
Latest
1 story
Sign inSign in1 story
The Delaware biotechnology company registered a new exempt securities notice with the SEC, reporting $10 million already raised from three investors.
SEC filing